<?xml version="1.0"?>
<oembed><version>1.0</version><provider_name>Site da Brakke Consulting</provider_name><provider_url>https://brakkeconsulting.com/pt</provider_url><title>News from Brakke Consulting</title><type>rich</type><width>600</width><height>338</height><html>&lt;blockquote class="wp-embedded-content" data-secret="qeZHnkIq5l"&gt;&lt;a href="https://brakkeconsulting.com/pt/1326/"&gt;Not&#xED;cias e notas de sa&#xFA;de animal de 26 de novembro de 2008&lt;/a&gt;&lt;/blockquote&gt;&lt;iframe sandbox="allow-scripts" security="restricted" src="https://brakkeconsulting.com/pt/1326/embed/#?secret=qeZHnkIq5l" width="600" height="338" title="&#x201C;Animal Health News &amp; Notes for November 26, 2008&#x201D; &#x2014; Brakke Consulting Website" data-secret="qeZHnkIq5l" frameborder="0" marginwidth="0" marginheight="0" scrolling="no" class="wp-embedded-content"&gt;&lt;/iframe&gt;&lt;script type="text/javascript"&gt;
/* &lt;![CDATA[ */
/*! This file is auto-generated */
!function(d,l){"use strict";l.querySelector&amp;&amp;d.addEventListener&amp;&amp;"undefined"!=typeof URL&amp;&amp;(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&amp;&amp;!/[^a-zA-Z0-9]/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret="'+t.secret+'"]'),o=l.querySelectorAll('blockquote[data-secret="'+t.secret+'"]'),c=new RegExp("^https?:$","i"),i=0;i&lt;o.length;i++)o[i].style.display="none";for(i=0;i&lt;a.length;i++)s=a[i],e.source===s.contentWindow&amp;&amp;(s.removeAttribute("style"),"height"===t.message?(1e3&lt;(r=parseInt(t.value,10))?r=1e3:~~r&lt;200&amp;&amp;(r=200),s.height=r):"link"===t.message&amp;&amp;(r=new URL(s.getAttribute("src")),n=new URL(t.value),c.test(n.protocol))&amp;&amp;n.host===r.host&amp;&amp;l.activeElement===s&amp;&amp;(d.top.location.href=t.value))}},d.addEventListener("message",d.wp.receiveEmbedMessage,!1),l.addEventListener("DOMContentLoaded",function(){for(var e,t,s=l.querySelectorAll("iframe.wp-embedded-content"),r=0;r&lt;s.length;r++)(t=(e=s[r]).getAttribute("data-secret"))||(t=Math.random().toString(36).substring(2,12),e.src+="#?secret="+t,e.setAttribute("data-secret",t)),e.contentWindow.postMessage({message:"ready",secret:t},"*")},!1)))}(window,document);
//# sourceURL=https://brakkeconsulting.com/wp-includes/js/wp-embed.min.js
/* ]]&gt; */
&lt;/script&gt;</html><description>printer friendly version ******************************************************************* Brakke Consulting&#x2019;s Animal Health News &amp; Notes for November 26, 2008 Copyright &copy; Brakke Consulting, Inc. &nbsp; Editor: Lynn Fondon, DVM, MBA ******************************************************************* IN THE NEWS : &nbsp; earnings news Central Garden &amp; Pet Evialis &nbsp; other news AB Science Albion Alpharma Ascor Chimici Biopharm Boehringer Ingelheim Vetmedica BOMAC Vets Plus Dainippon Sumitomo Pharma IDEXX King Pharmaceuticals Modern Veterinary Therapeutics Nestle Purina Vetoquinol&nbsp; &nbsp; ******************************************************************* 2008 US FLEA CONTROL &amp; HEARTWORM MARKETS LAST DAY FOR EARLY-BIRD DISCOUNT IS NOV. 26! &nbsp; Contact Dr. Lynn Fondon at lfondon@brakkeconsulting.com or 972-243-4033 to order or for more information. &nbsp; www.BrakkeConsulting.com &nbsp; ******************************************************************* COMPANY EARNINGS RELEASES &nbsp; &gt; Evialis has reported revenue of EUR 304 million ($439 million) for the first quarter of the 2008-2009 financial year ended September 30, an increase of nearly 64%. The increase reflected the high price of raw materials as well as the contribution of acquired businesses. On a like-for-like basis, revenue increased 26% over the previous year. (Animal Pharm) &nbsp; &gt; Central Garden &amp; Pet reported results for the fourth quarter ended September 27, 2008. Net sales for the Pet Products segment were $226 million, an increase of 2% compared to the year-ago period.&nbsp; (company website)&nbsp;&nbsp; &nbsp; ******************************************************************* COMPANY NEWS RELEASES &nbsp; &gt; King Pharmaceuticals, Inc. and Alpharma Inc. announced that the two companiesView Full Post;</description></oembed>
